• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-内酰胺类过敏记录更新的适宜性:过敏服务咨询后的评估。

Appropriateness of Beta-Lactam Allergy Record Updates After an Allergy Service Consult.

机构信息

Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL, USA.

Department of Pharmacy Practice, Midwestern University, Chicago College of Pharmacy, Downers Grove, IL, USA.

出版信息

J Pharm Pract. 2020 Jun;33(3):243-246. doi: 10.1177/0897190018797767. Epub 2018 Sep 4.

DOI:10.1177/0897190018797767
PMID:30180773
Abstract

BACKGROUND

Many patients with a self-reported penicillin allergy go on to tolerate beta-lactam antibiotics. Allergy specialists may be consulted to determine the nature and extent of the allergy. However, electronic allergy records must be appropriately updated such that recommendations are carried forward.

OBJECTIVE

To determine the percentage of patients who have their electronic allergy record updated after an allergy service consult (ASC).

METHODS

This was a retrospective study of patients with at least 1 documented beta-lactam allergy and had an ASC during (inpatient) or prior to (outpatient) hospital admission at Northwestern Memorial Hospital and Prentice Women's Hospital in Chicago, Illinois.

RESULTS

Within the study period, a total of 26 526 patients were identified as having a documented antibiotic allergy, with 21 657 patients (81.6% of patients with allergies) having a listed beta-lactam allergy. Of these patients, 1689 (7.8%) patients were identified as having an ASC during or prior to admission, with 598 patients meeting inclusion criteria. Changes in the allergy record were recommended by the ASC for 62% (n = 371) of patients; however, the allergy record was updated after the ASC in 74.9% (n = 278) of patients.

CONCLUSION

ASC recommendations to delabel a patient as beta-lactam allergic must result in updating the allergy record in order to optimize future treatment. Given the low proportion of allergy-labeled patients tested, programs outside formal ASCs should be considered.

摘要

背景

许多自述青霉素过敏的患者实际上能够耐受β-内酰胺类抗生素。可能会咨询过敏专科医生以确定过敏的性质和程度。但是,必须适当地更新电子过敏记录,以便将建议延续下去。

目的

确定在过敏专科医生就诊(ASC)后,有多少患者更新了他们的电子过敏记录。

方法

这是一项回顾性研究,研究对象为至少有 1 次记录的β-内酰胺类抗生素过敏史且在西北纪念医院和芝加哥 Prentice 妇女医院住院期间(住院患者)或住院前(门诊患者)接受过 ASC 的患者。

结果

在研究期间,共确定了 26526 名患者存在记录在案的抗生素过敏,其中 21657 名(81.6%的过敏患者)患者有β-内酰胺类过敏记录。在这些患者中,有 1689 名(7.8%的过敏患者)患者在住院期间或住院前接受了 ASC,其中 598 名患者符合纳入标准。ASC 建议改变过敏记录的患者有 62%(n=371),但在 ASC 后有 74.9%(n=278)的患者更新了过敏记录。

结论

ASC 建议将患者从β-内酰胺类过敏标签中删除,必须更新过敏记录,以优化未来的治疗。鉴于接受过敏测试的标记过敏患者比例较低,应考虑在正式 ASC 之外开展相关项目。

相似文献

1
Appropriateness of Beta-Lactam Allergy Record Updates After an Allergy Service Consult.β-内酰胺类过敏记录更新的适宜性:过敏服务咨询后的评估。
J Pharm Pract. 2020 Jun;33(3):243-246. doi: 10.1177/0897190018797767. Epub 2018 Sep 4.
2
Incidence of interruptive penicillin allergy alerts in patients with previously documented beta-lactam exposure: Potential for leveraging the electronic health record to identify erroneous allergies.曾有β-内酰胺暴露史患者中青霉素过敏警示中断的发生率:利用电子健康记录识别错误过敏反应的可能性。
Infect Control Hosp Epidemiol. 2022 Sep;43(9):1108-1111. doi: 10.1017/ice.2021.329. Epub 2021 Aug 13.
3
Administration of β-lactam antibiotics to patients with reported penicillin allergy in the emergency department.在急诊科,给报告有青霉素过敏史的患者使用β-内酰胺类抗生素。
Am J Emerg Med. 2023 Jun;68:119-123. doi: 10.1016/j.ajem.2023.03.013. Epub 2023 Mar 21.
4
Outcomes from an inpatient beta-lactam allergy guideline across a large US health system.美国大型医疗体系中住院患者β-内酰胺类抗生素过敏指南的结果。
Infect Control Hosp Epidemiol. 2019 May;40(5):528-535. doi: 10.1017/ice.2019.50. Epub 2019 Mar 27.
5
Full-dose challenge of moderate, severe, and unknown beta-lactam allergies in the emergency department.在急诊科对中度、重度和未知β-内酰胺类过敏进行全剂量挑战。
Acad Emerg Med. 2024 Aug;31(8):777-781. doi: 10.1111/acem.14893. Epub 2024 Mar 21.
6
Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: A pilot project.药剂师主导的β-内酰胺类药物过敏访谈对住院患者抗菌治疗的影响:一项试点项目。
J Am Pharm Assoc (2003). 2016 Nov-Dec;56(6):665-669. doi: 10.1016/j.japh.2016.05.005. Epub 2016 Oct 10.
7
Promoting β-lactam utilization through suppression of electronic medical record cross-allergy alerts.通过抑制电子病历交叉过敏警示来促进β-内酰胺类药物的使用。
Am J Health Syst Pharm. 2022 May 24;79(Suppl 2):S43-S52. doi: 10.1093/ajhp/zxac040.
8
Confronting the Challenge of Beta-Lactam Allergies: A Quasi-Experimental Study Assessing Impact of Pharmacy-Led Interventions.应对β-内酰胺类药物过敏的挑战:一项评估药学主导干预措施影响的准实验研究
J Pharm Pract. 2019 Apr;32(2):139-146. doi: 10.1177/0897190017743154. Epub 2017 Nov 21.
9
Implementation of a Pharmacist-Driven Detailed Penicillin Allergy Interview.实施药师主导的详细青霉素过敏访谈。
Ann Pharmacother. 2020 Apr;54(4):364-370. doi: 10.1177/1060028019884874. Epub 2019 Nov 8.
10
Use of a Penicillin Allergy Screening Algorithm and Penicillin Skin Testing for Transitioning Hospitalized Patients to First-Line Antibiotic Therapy.使用青霉素过敏筛查算法和青霉素皮试,将住院患者过渡到一线抗生素治疗。
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1349-1355. doi: 10.1016/j.jaip.2017.11.012. Epub 2017 Dec 11.

引用本文的文献

1
The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021: A Systematic Review.从 2000 年到 2021 年,利用电子健康记录研究药物诱导的超敏反应:系统评价。
Immunol Allergy Clin North Am. 2022 May;42(2):453-497. doi: 10.1016/j.iac.2022.01.004. Epub 2022 Mar 31.
2
Standardization and Updating of a Drug Allergy Testing Program: The McGill Experience and Impact on Pharmacy Activities.药物过敏测试项目的标准化与更新:麦吉尔大学的经验及对药学活动的影响
Can J Hosp Pharm. 2020 Jan-Feb;73(1):45-51. Epub 2020 Feb 1.
3
Causative drugs for drug-induced cutaneous reactions in central China: a 608-case analysis.
中国中部地区药物性皮肤反应的致病药物:608例病例分析
An Bras Dermatol. 2019 Nov-Dec;94(6):664-670. doi: 10.1016/j.abd.2019.01.007. Epub 2019 Oct 26.
4
Antimicrobial Stewardship Interventions to Combat Antibiotic Resistance: an Update on Targeted Strategies.对抗抗生素耐药性的抗菌药物管理干预措施:靶向策略的最新进展
Curr Infect Dis Rep. 2019 Aug 31;21(10):33. doi: 10.1007/s11908-019-0689-2.